Waxman Launches Salvo Against FDA Pre-Emption Of State Tort Suits
This article was originally published in The Tan Sheet
Executive Summary
House Oversight and Government Reform Committee Chairman Henry Waxman has lined up prominent physicians, a former FDA commissioner and a celebrity to make a case against pre-emption
You may also be interested in...
Waxman Report Showing FDA Pre-emption Split May Alter Legal Debate
A report from influential House leader Henry Waxman exposes a rift between senior FDA staff and the agency's Office of Chief Counsel that could help the plaintiff in the FDA pre-emption case that has reached the Supreme Court
Drug Industry Braces For Supreme Court Ruling In Wyeth Pre-emption Case
This week everyone's attention is riveted on the presidential election. But for the pharmaceutical industry there is another issue just as compelling. On Nov. 3, the U.S. Supreme Court will hear oral arguments in the case that will decide the future of product liability litigation
Waxman Report Showing FDA Pre-emption Split May Alter Legal Debate
A report from influential House leader Henry Waxman exposes a rift between senior FDA staff and the agency's Office of Chief Counsel that could help the plaintiff in the FDA pre-emption case that has reached the Supreme Court